Harbin Jixianglong Biotech Co., Ltd. recalls
Harbin Jixianglong Biotech Co., Ltd. is named on 1 recall in Recall Relay's records since November 2023, from FDA (2 recalled products: FDA lists each product as its own recall); the most recent was February 13, 2026.
All 2 recalled products, newest first.
-
Class IIofficial
Harbin Jixianglong Biotech Co., Ltd. recalls SemaglutideCGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
-
Class IIofficial
Harbin Jixianglong Biotech Co., Ltd. recalls SemaglutideCGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Harbin Jixianglong Biotech Co., Ltd. or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts